weekly featured products

Best Selling Products

Free Shipping on all orders

Get Free Shipping on all orders over $75 and free returns to our UK returns centre! Items are dispatched from the US and will arrive in 5-8 days.

Amazing customer service

Get Free Shipping on all orders over $75 and free returns to our UK returns centre! Items are dispatched from the US and will arrive in 5-8 days.

No Customs or Duty Fees!

We pay these fees so you don’t have to! The total billed at checkout is the final amount you pay, inclusive of VAT, with no additional charges at the time of delivery!

Zepbound by Lilly

ZEPBOUND™ is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of:

  • 30 kg/m2 or greater (obesity) or
  • 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea, or cardiovascular disease).

 

Recommended Dosage

  • The recommended starting dosage of ZEPBOUND is 2.5 mg injected subcutaneously once weekly. The 2.5 mg dosage is for treatment initiation and is not intended for chronic weight management.
  • After 4 weeks, increase the dosage to 5 mg injected subcutaneously once weekly.
  • The dosage may be increased in 2.5 mg increments, after at least 4 weeks on the current dose.
  • The recommended maintenance dosages of ZEPBOUND in adults are 5 mg, 10 mg, or 15 mg injected subcutaneously once weekly.
  • Consider treatment response and tolerability when selecting the maintenance dosage. If patients do not tolerate a maintenance dosage, consider a lower maintenance dosage.
  • The maximum dosage of ZEPBOUND is 15 mg injected subcutaneously once weekly.

 

Recommendations Regarding Missed Dose

  • If a dose is missed, instruct patients to administer ZEPBOUND as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once weekly dosing schedule.
  • The day of weekly administration can be changed, if necessary, as long as the time between the two doses is at least 3 days (72 hours).

 

Important Administration Instructions

  • Prior to initiation of ZEPBOUND, train patients and caregivers on proper injection technique. Refer to the accompanying Instructions for Use for complete administration instructions with illustrations.
  • Inspect ZEPBOUND visually before use. It should appear clear and colorless to slightly yellow. Do not use ZEPBOUND if particulate matter or discoloration is seen.
  • Administer ZEPBOUND once weekly at any time of day, with or without meals.
  • Inject ZEPBOUND subcutaneously in the abdomen, thigh, or upper arm.
  • Rotate injection sites with each dose.